This article is a review of the MultiCASE Inc. software and expert systems and their use to assess acute toxicity, mutagenicity, carcinogenicity, and other health effects. It is demonstrated that MultiCASE expert systems satisfy the guidelines of the Organisation for Economic Cooperation and Development (OECD) principles and that the portfolio of available endpoints closely overlaps with the list of tests required by REACH.
No takes yet. Share an insight, caveat, or question.
Saiakhov et al. (2008) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: